Elevated serum B-cell activating factor in patients with chronic urticaria

Human Immunology

Volumn 73, Issue 6, 2012, Pages 620-622

  Kessel, Aharon ^a   Yaacoby Bianu, Karin ^a   Vadasz, Zahava ^a   Peri, Regina ^a   Halazs, Katy ^a   Toubi, Elias ^a  

^a BNAI ZION MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; B CELL ACTIVATING FACTOR; IMMUNOGLOBULIN E; THYROID ANTIBODY;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; CHRONIC URTICARIA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SKIN TEST; T LYMPHOCYTE;

ADULT; ANTIBODIES, ANTINUCLEAR; AUTOANTIBODIES; B-CELL ACTIVATING FACTOR; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHRONIC DISEASE; FEMALE; HUMANS; IMMUNOGLOBULIN E; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SKIN TESTS; URTICARIA;

EID: 84861768963     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2012.03.016     Document Type: Article

References (19)

1. Hide M., Francies D.M., Grattan C.E.H., Hakimi J., Kacham J.P., Greave M.W. Autoantibodies against the high affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med 1993, 328:1599-1604.
2. Grattan C.E., Francis D.M., Hide M., Greave M.W. Detection of circulating histamine releasing autoantibodies with functional properties of anti-IgE in chronic urticaria. Clin Exp Allergy 1991, 21:695-704.
3. Toubi E., Adir-Shani A., Kessel A., Shmuel Z., Sabo E., Hacham H. Immune aberrations in B and T lymphocytes derived from chronic urticaria patients. J Clin Immunol 2000, 20:371-378.
4. Kessel A., Helou W., Bamberger E., Sabo E., Nusem D., Panassof J., et al. Elevated serum total IgE - a potential marker for severe chronic urticaria. Int Arch Allergy Immunol 2010, 153(3):288-293.
5. Kalled S.L. The role of BAFF in immune function and implications for autoimmunity. Immunol Rev 2005, 204:43-54.
6. Mackay F., Silveira P.A., Brink R. B cells and the BAFF/APRIL axis: fast-forward on autoimmunity and signaling. Curr Opin Immunol 2007, 19(3):327-336.
7. Mackay F., Silveira P.A., Brink R. B cells and the BAFF/APRIL axis: fast-forward on autoimmunity and signaling. Curr Opin in Immunol 2007, 19:327-336.
8. Pers J.O., Daridon C., Devauchelle V., Jousse S., Saraux A., Jamin C., et al. BAFF overexpression is associated with autoantibody production in autoimmune diseases. Ann N Y Acad Sci 2005, 1050:34-39.
9. Becker-Merok A., Nikolaisen C., Nossent H.C. B-lymphocyte activating factor in systemic lupus erythematosus and rheumatoid arthritis in relation to autoantibody levels, disease measures and time. Lupus 2006, 15(9):570-576.
10. Breneman D., Bronsky A.K., Bruce S. Cetirizine and astemisone therapy for chronic urticaria: a double-blind, placebo-controlled, comparative trial. J Am Acad Dermatol 1995, 33:192-198.
11. Sabroe R.A., Grattan C.E.I., Francis D.M., Barr R.M., Black A.K., Greaves M.W. The autologous serum skin test: a screening test for autoantibodies in chronic idiopathic urticaria. Br J Dermatol 1999, 140:446-452.
12. Kang J.S., Yoon Y.D., Ahn J.H., Kim S.C., Kim K.H., Kim H.M., et al. B cell- activating factor is a novel diagnosis parameter for asthma. Int Arch Allergy Immunol 2006, 141(2):181-188.
13. Kato A., Xiao H., Chustz R.T., Liu M.C., Schleimer R.P. Local release of B cell-activating factor of the TNF family after segmental allergen challenge of allergic subjects. J Allergy Clin Immunol 2009, 123(2):369-375.
14. Jee H.M., Kim K.W., Hong J.Y., Sohn M.H., Kim K.E. Increased serum B cell-activating factor level in children with atopic dermatitis. Clin Exp Dermatol 2009, 53:795-800.
15. Matsushita T., Fujimoto M., Echigo T., Matsushita Y., Shimada Y., et al. Elevated serum levels of APRIL, but not BAFF, in patients with atopic dermatitis. Exp Dermatol 2008, 17:197-202.
16. Chen Y., Lind Enoksson S., Johansson C., Karlsson M.A., Lundeberg L., Nilsson G., et al. The expression of BAFF, APRIL and TWEAK is altered in eczema skin but not in the circulation of atopic and seborrheic eczema patients. PLoS One 2011, 6(7):e22202.
17. Petri M., Stohl W., Chatham W., McCune W.J., Chevrier M., Ryel J., et al. Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus. Arthritis Rheum 2008, 58(8):2453-2459.
18. Nishino Y., Tamai M., Kawakami A., Koga T., Makiyama J., Maeda Y., et al. Serum levels of BAFF for assessing the disease activity of Takayasu arteritis. Clin Exp Rheumatol 2010, 28(1 Suppl. 57):14-17.
19. Chakravarty S.D., Yee A.F., Paget S.A. Rituximab successfully treats refractory chronic autoimmune urticaria caused by IgE receptor autoantibodies. J Allergy Clin Immunol 2011, 128(6):1354-1355.